KMT2A and neoplasm: In an MLL-AF9 oncogene-driven AML mouse model, short hairpin RNA (shRNA)-mediated Zeb1 knockdown reduced bone marrow infiltration in vivo, and in vitro studies showed impaired tumor cell invasion (59).